| Myeloproliferative Disorder Basics |
|
What are MPDs?
Myeloproliferative disorders, or MPD, are a group of hematologic (blood) diseases that affect production of blood cells in the bone marrow. MPDs are characterized by the over-production of certain types of cells, particularly red blood cells (which carry oxygen), platelets (which assist in blood clotting) and white blood cells (which fight disease).
MPD can strike at any age and have no known cause. Symptoms, prognosis and progression vary depending on the patient's age, health and type of disease. Some patients may have slowly progressing disease that may not require any treatment beyond careful monitoring, while others may progress to more advanced stages or acute myelogenous leukemia.
- Disease Types & Symptoms - There are several types of myeloproliferative disorders, all of which are treated at M. D. Anderson. This site deals with Philadelphia chromosome-negative MPDs.
|
| Myeloproliferative Disorder Treatment at M. D. Anderson |
|
Request an Appointment
Submit our Online Self-Referral Form or call 1-877-MDA-6789. |
Clinical Trials
M. D. Anderson MPD specialists are working to develop effective treatments and are testing promising therapies in clinical trials. |
Treatment at M. D. Anderson
Patients with myeloproliferative disorders are treated in M. D. Anderson's Leukemia Center. For information, call (713) 563-2000. For clinical trial information, call an MPD specialist.
Treatment - Treatments for MPD are generally used to control disease symptoms. For some patients, a bone marrow transplant may be an option.
Clinical Trials - M. D. Anderson specializes in developing new medications and currently has several clinical trials for MPD patients.
MPD Specialists - M. D. Anderson has a team of experts who treat myeloproliferative disorders and conduct research to find new treatments for these diseases.
|
| Myeloproliferative Disorder Education & Support |
|
Education & Support
|
|
| News & Articles |
|
Leukemia Insights Newsletter -
A free quarterly newsletter for physicians and other health professionals about the latest leukemia news, research and resources.
Spring 2005: This issue is devoted to clinical studies being offered at M. D. Anderson Cancer Center for myeloproliferative disorders (MPDs). Although they comprise a relatively rare subset of hematologic disorders, several new and promising therapies are recently available and will be discussed.
Current Issue
Subscribe Now |
|
|
|
|
A cancer diagnosis comes with many questions. askMDAnderson has answers.
1-877-MDA-6789
International patients call:
(713) 745-0450 |
www.mdanderson.org/ask
En Español | |
| Links & Resources |
|
NOTE: Pages will open in a new browser window. M. D. Anderson does not endorse external sites.
MPD Foundation
MPD Resource Center
National Cancer Institute
The Mastocytosis Society
Cancer Information Service
1-800-4-CANCER
Talk with a health information specialist to learn more about a particular type of cancer, treatment options and community resources. | |
